Inhibition of interleukin-10 signaling in lung dendritic cells by toll-like receptor 4 ligands

Experimental Lung Research

Volumn 35, Issue 1, 2009, Pages 1-28

  Jose, Purnima ^a   Avdiushko, Margarita G ^a   Akira, Shizuo ^b   Kaplan, Alan M ^a   Cohen, Donald A ^a,c  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b OSAKA UNIVERSITY   (Japan)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Bone marrow derived dendritic cells; Interleukin 10; Lipopolysaccharide; Lung dendritic cells; Toll like receptor 4

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 12; LIGAND; LIPOPOLYSACCHARIDE; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; STAT3 PROTEIN; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; COMPETITIVE INHIBITION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; IMMUNOREACTIVITY; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STIMULUS RESPONSE;

ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; LIGANDS; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHORYLATION; RESPIRATORY MUCOSA; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTOR 4;

EID: 60749131965     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140802389727     Document Type: Article

References (85)

1. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A: IL-10 inhibits cytokine production by activated macrophages. J Immunol. 1991;147:3815-3822.
2. Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S: Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med. 1994;179:1695-1699.
3. Joyce DA, Gibbons DP, Green P, Steer JH, Feldmann M, Brennan FM: Two inhibitors of proinflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol. 1994;24:2699-2705.
4. Bonfield TL, Konstan MW, Burfeind P, Panuska JR, Hilliard JB, Berger M: Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol. 1995;13:257-261.
5. Fernandez S, Jose P, Avdiushko MG, Kaplan AM, Cohen DA: Inhibition of IL-10 receptor function in alveolar macrophages by Toll-like receptor agonists. J Immunol. 2004;172:2613-2620.
6. Buelens C, Verhasselt V, De Groote D, Thielemans K, Goldman M, Willems F: Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage- colony-stimulating factor. Eur J Immunol. 1997;27:756-762.
7. Tryzmel J, Miskolci V, Castro-Alcaraz S, Vancurova I, Davidson D: Interleukin-10 inhibits proinflammatory chemokine release by neutrophils of the newborn without suppression of nuclear factor-kappa B. Pediatr Res. 2003;54:382-386.
8. Fiorentino DF, Zlotnik A, Vieira P, et al: IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol. 1991;146:3444-3451.
9. Weber-Nordt RM, Riley JK, Greenlund AC, Moore KW, Darnell JE, Schreiber RD: Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain. J Biol Chem. 1996;271:27954-27961.
10. Wehinger J, Gouilleux F, Groner B, Finke J, Mertelsmann R, Weber-Nordt RM: IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes. FEBS Lett. 1996;394:365-370.
11. Finbloom DS, Winestock KD: IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J Immunol. 1995;155:1079-1090.
12. Takeda K, Clausen BE, Kaisho T, et al: Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity. 1999;10:39-49.
13. Riley JK, Takeda K, Akira S, Schreiber RD: Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J Biol Chem. 1999;274:16513-16521.
14. Williams L, Bradley L, Smith A, Foxwell B: Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol. 2004;172:567-576.
15. Rahimi AA, Gee K, Mishra S, Lim W, Kumar A: STAT-1 mediates the stimulatory effect of IL-10 on CD14 expression in human monocytic cells. J Immunol. 2005;174:7823-7832.
16. Bingisser RM, Holt PG: Immunomodulating mechanisms in the lower respiratory tract: nitric oxide mediated interactions between alveolar macrophages, epithelial cells, and T-cells. Swiss Med Wkly. 2001;131:171-179.
17. Soltys J, Bonfield T, Chmiel J, Berger M: Functional IL-10 deficiency in the lung of cystic fibrosis (cftr(-/-)) and IL-10 knockout mice causes increased expression and function of B7 costimulatory molecules on alveolar macrophages. J Immunol. 2002;168:1903-1910.
18. Raychaudhuri B, Fisher CJ, Farver CF, et al: Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages. Cytokine. 2000;12:1348-1355.
19. Isler P, de Rochemonteix BG, Songeon F, Boehringer N, Nicod LP: Interleukin-12 production by human alveolar macrophages is controlled by the autocrine production of interleukin-10. Am J Respir Cell Mol Biol. 1999;20:270-278.
20. Martinez JA, King TE Jr, Brown K, et al: Increased expression of the interleukin-10 gene by alveolar macrophages in interstitial lung disease. Am J Physiol. 1997;273(3 Pt 1):L676-L683.
21. Armstrong L, Jordan N, Millar A: Interleukin 10 (IL-10) regulation of tumour necrosis factor alpha (TNF-alpha) from human alveolar macrophages and peripheral blood monocytes. Thorax 1996;51:143-149.
22. Sertl K, Takemura T, Tschachler E, Ferrans VJ, Kaliner MA, Shevach EM: Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura. J Exp Med. 1986;163:436-451.
23. Vermaelen KY, Carro-Muino I, Lambrecht BN, Pauwels RA: Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J Exp Med. 2001;193:51-60.
24. Holt PG, Haining S, Nelson DJ, Sedgwick JD: Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J Immunol. 1994;153:256-261.
25. Jahnsen FL, Strickland DH, Thomas JA, et al: Accelerated antigen sampling and transport by airway mucosal dendritic cells following inhalation of a bacterial stimulus. J Immunol. 2006;177:5861-5867.
26. Hawiger D, Inaba K, Dorsett Y, et al: Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med. 2001;194:769-779.
27. Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N: Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med. 2000;191:423-434.
28. Jonuleit H, Schmitt E, Steinbrink K, Enk AH: Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 2001;22:394-400.
29. Agrawal S, Agrawal A, Doughty B, et al: Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen- activated protein kinase and c-Fos. J Immunol. 2003;171:4984-4989.
30. Lambrecht BN, Salomon B, Klatzmann D, Pauwels RA: Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol. 1998;160:4090-4097.
31. Worgall S, Kikuchi T, Singh R, Martushova K, Lande L, Crystal RG: Protection against pulmonary infection with Pseudomonas aeruginosa following immunization with P. aeruginosa-pulsed dendritic cells. Infect Immun. 2001;69:4521-4527.
32. Wang B, Zhuang L, Fujisawa H, et al: Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J Immunol 1999;162:277-283.
33. Wakkach A, Cottrez F, Groux H: Differentiation of regulatory T cells 1 is induced by CD2 costimulation. J Immunol. 2001;167:3107-3113.
34. Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H: Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity. 2003;18:605-617.
35. Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk AH: Induction of tolerance by IL-10-treated dendritic cells. J Immunol. 1997;159:4772-4780.
36. van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF: Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis. 1996;174:994-1000.
37. Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Goodman RE, Standiford TJ: Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol. 1995;155:722-729.
38. Du Z, Kelly E, Mecklenbrauker I, et al: Selective regulation of IL-10 signaling and function by zymosan. J Immunol. 2006;176:4785-4792.
39. Kadowaki N, Ho S, Antonenko S, et al: Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med. 2001;194:863-869.
40. Jarrossay D, Napolitani G, Colonna M, Sallusto F, Lanzavecchia A: Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol. 2001;31:3388-3393.
41. Kawai T, Adachi O, Ogawa T, Takeda K: Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 1999;11:115-122.
42. Kawai T, Takeuchi O, Fujita T, et al: Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol. 2001;167:5887-5894.
43. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 1997;388:394-397.
44. Peters IR, Helps CR, Calvert EL, Hall EJ, Day MJ: Cytokine mRNA quantification in histologically normal canine duodenal mucosa by real-time RT-PCR. Vet Immunol Immunopathol. 2005;103:101-111.
45. Lutz MB, Kukutsch N, Ogilvie AL, et al: An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 1999;223:77-92.
46. Cochand L, Isler P, Songeon F, Nicod LP: Human lung dendritic cells have an immature phenotype with efficient mannose receptors. Am J Respir Cell Mol Biol. 1999;21:547-554.
47. Holt PG, Oliver J, McMenamin C, Schon-Hegrad MA: Studies on the surface phenotype and functions of dendritic cells in parenchymal lung tissue of the rat. Immunology. 1992;75:582-587.
48. Webb TJ, Sumpter TL, Thiele AT, Swanson KA, Wilkes DS: The phenotype and function of lung dendritic cells. Crit Rev Immunol. 2005;25:465-491.
49. Takanashi S, Hasegawa Y, Kanehira Y, et al: Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers. Eur Respir. J 1999;14:309-314.
50. Holt PG, Schon-Hegrad MA. Localization of T cells, macrophages and dendritic cells in rat respiratory tract tissue: implications for immune function studies. Immunology. 1987;62:349-356.
51. Schon-Hegrad MA, Oliver J, McMenamin PG, Holt PG: Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia)-bearing dendritic cells (DC) in the conducting airways. J Exp Med. 1991;173:1345-1356.
52. Lagranderie M, Nahori MA, Balazuc AM, et al: Dendritic cells recruited to the lung shortly after intranasal delivery of Mycobacterium bovis BCG drive the primary immune response towards a type 1 cytokine production. Immunology. 2003;108:352-364.
53. Smit JJ, Rudd BD, Lukacs NW: Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J Exp Med. 2006;203:1153-1159.
54. Pollard AM, Lipscomb MF: Characterization of murine lung dendritic cells: similarities to Langerhans cells and thymic dendritic cells. J Exp Med. 1990;172:159-167.
55. Steinman RM, Cohn ZA: Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med. 1973;137:1142-1162.
56. Steinman RM, Lustig DS, Cohn ZA: Identification of a novel cell type in peripheral lymphoid organs of mice. 3. Functional properties in vivo. J Exp Med. 1974;139:1431-1445.
57. Swanson KA, Zheng Y, Heidler KM, Zhang ZD, Webb TJ, Wilkes DS: Flt3-ligand, IL-4, GM-CSF, and adherence-mediated isolation of murine lung dendritic cells: assessment of isolation technique on phenotype and function. J Immunol. 2004;173:4875-4881.
58. Larsen CP, Ritchie SC, Hendrix R, et al. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol. 1994;152:5208-5219.
59. Bhattacharyya S, Sen P, Wallet M, Long B, Baldwin AS Jr, Tisch R: Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the PI3K/Akt pathway and of IkappaB kinase activity. Blood. 2004;104:1100-1109.
60. Nolan KF, Strong V, Soler D, et al: IL-10-conditioned dendritic cells, decommissioned for recruitment of adaptive immunity, elicit innate inflammatory gene products in response to danger signals. J Immunol. 2004;172:2201-2209.
61. Jang MH, Sougawa N, Tanaka T, et al. CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J Immunol. 2006;176:803-810.
62. Ahmed ST, Ivashkiv LB: Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways. J Immunol. 2000;165:5227-5237.
63. Avdiushko R, Hongo D, Lake-Bullock H, Kaplan A, Cohen D: IL-10 receptor dysfunction in macrophages during chronic inflammation. J Leukoc Biol. 2001;70:624-632.
64. Herrero C, Hu X, Li WP, et al. Reprogramming of IL-10 activity and signaling by IFN-gamma. J Immunol. 2003;171:5034-5041.
65. Park-Min KH, Antoniv TT, Ivashkiv LB: Regulation of macrophage phenotype by long-term exposure to IL-10. Immunobiology. 2005;210:77-86.
66. Doyle SL, O'Neill LA: Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol. 2006;72:1102-1113.
67. Ogawa S, Lozach J, Benner C, et al. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell. 2005;122:707-721.
68. Wietek C, Miggin SM, Jefferies CA, O'Neill LA: Interferon regulatory factor-3-mediated activation of the interferon-sensitive response element by Toll-like receptor (TLR) 4 but not TLR3 requires the p65 subunit of NF-kappa. J Biol Chem. 2003;278:50923-50931.
69. Bodger K, Wyatt JI, Heatley RV: Gastric mucosal secretion of interleukin-10: relations to histopathology, Helicobacter pylori status, and tumour necrosis factor-alpha secretion. Gut. 1997;40:739-744.
70. Castle PE, Hildesheim A, Bowman FP, et al. Cervical concentrations of interleukin-10 and interleukin-12 do not correlate with plasma levels. J Clin Immunol. 2002;22:23-27.
71. Corne JM, Lau L, Scott SJ, Davies R, Johnston SL, Howarth PH: The relationship between atopic status and IL-10 nasal lavage levels in the acute and persistent inflammatory response to upper respiratory tract infection. Am J Respir Crit Care Med. 2001;163:1101-1107.
72. Gasche C, Bakos S, Dejaco C, Tillinger W, Zakeri S, Reinisch W. IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease. J Clin Immunol. 2000;20:362-370.
73. Gravitt PE, Hildesheim A, Herrero R, et al. Correlates of IL-10 and IL-12 concentrations in cervical secretions. J Clin Immunol. 2003;23:175-183.
74. Karttunen RA, Karttunen TJ, Yousfi MM, el-Zimaity HM, Graham DY, el-Zaatari FA: Expression of mRNA for interferon-gamma, interleukin-10, and interleukin-12 (p40) in normal gastric mucosa and in mucosa infected with Helicobacter pylori. Scand J Gastroenterol. 1997;32:22-27.
75. KleinJan A, Dijkstra MD, Boks SS, Severijnen LA, Mulder PG, Fokkens WJ: Increase in IL-8, IL-10, IL-13, and RANTES mRNA levels (in situ hybridization) in the nasal mucosa after nasal allergen provocation. J Allergy Clin Immunol. 1999;103(3 Pt 1):441-450.
76. Peeters D, Peters IR, Farnir F, Clercx C, Day MJ: Real-time RT-PCR quantification of mRNA encoding cytokines and chemokines in histologically normal canine nasal, bronchial and pulmonary tissue. Vet Immunol Immunopathol. 2005;104:195-204.
77. Scavuzzo MC, Rocchi V, Fattori B, et al. Cytokine secretion in nasal mucus of normal subjects and patients with allergic rhinitis. Biomed Pharmacother. 2003;57:366-371.
78. Sohn BH, Moon HB, Kim TY, et al. Interleukin-10 up-regulates tumour-necrosis-factor-alpha-related apoptosis-inducing ligand (TRAIL) gene expression in mammary epithelial cells at the involution stage. Biochem. J 2001;360(Pt 1):31-38.
79. van Benten IJ, van Drunen CM, Koevoet JL, et al. Reduced nasal IL-10 and enhanced TNFalpha responses during rhinovirus and RSV-induced upper respiratory tract infection in atopic and nonatopic infants. J Med Virol. 2005;75:348-357.
80. Ajuebor MN, Das AM, Virag L, Szabo C, Perretti M: Regulation of macrophage inflammatory protein-1 alpha expression and function by endogenous interleukin-10 in a model of acute inflammation. Biochem Biophys Res Commun. 1999;255:279-282.
81. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683-765.
82. Ji JD, Tassiulas I, Park-Min KH, et al. Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis. J Exp Med. 2003;197:1573-1583.
83. MacDonald KP, Pettit AR, Quinn C, Thomas GJ, Thomas R: Resistance of rheumatoid synovial dendritic cells to the immunosuppressive effects of IL-10. J Immunol. 1999;163:5599-5607.
84. Mongan AE, Ramdahin S, Warrington RJ: Interleukin-10 response abnormalities in systemic lupus erythematosus. Scand J Immunol. 1997;46:406-412.
85. Schwacha MG, Schneider CP, Bland KI, Chaudry IH: Resistance of macrophages to the suppressive effect of interleukin-10 following thermal injury. Am J Physiol. 2001;281:C1180-C1187.